Andrew Lipsky

Assistant Professor @ColumbiaMed Hematologist-Oncologist @ColumbiaCancer @nyphospital Specializing in CLL #CancerGenomics

[Jennifer Amengual @jenamengual]

@OncLive State of the Science Summit- Westchester Jan 16 Dinner & Discussions-COME JOIN US! https://t.co/JQkFwMWTS7……
Columbia Faculty:
@JoeJurcic-MF
@Sunil_G_Iyer-MDS
@andrewlipskymd-BTKi
@hjcherng-Bispecifics
@jenamengual-Top 5 ASH Abstracts
@columbiacancer
#curelymphoma

[Jennifer Amengual @jenamengual]

Please join us for @OncLive State of the Science Summit in Westchester the evening of Jan 16!
https://t.co/JQkFwMXrHF
Columbia Colleagues Presenting:
@JoeJurcic -MF
@Sunil_G_Iyer -MDS
@andrewlipskymd -BTKi
@hjcherng -Bispecifics
Top 5 ASH Abstracts
@columbiacancer
#curelymphoma

[Andrew Lipsky @andrewlipskymd]

@JohnPLeonardMD @DannyLuan6 @WeillCornell @WCMDeptofMed @WCMLymphoma Dr. Luan is a rockstar!!

[ACS Journal Cancer @JournalCancer]

New review from @andrewlipskymd and Nicole Lamanna MD provides the latest approaches for novel targeted combination strategies in chronic lymphocytic leukemia: https://t.co/39uSLIByeA @OncoAlert @columbiacancer #LeuSM

[Sean Carroll @seanmcarroll]

Too many people have political philosophies founded on the idea that other people are mostly bums who deserve to suffer.

[Andrew Lipsky @andrewlipskymd]

Great to meet you, Petra! Fantastic job on your case presentation!

[Petra Ćaćić @petra_cacic]

I had an opportunity to participate in the #OMI Internal medicine Seminar in Salzburg and it was really an exceptional experience! Many thanks to @TejaKapoor @andrewlipskymd @KristinBurkart3 and other faculty members for your precious time and outstanding lectures.
#AAF

[Andrew Lipsky @andrewlipskymd]

@c_thieblemont Nice job loic!

[Andrew Lipsky @andrewlipskymd]

@david_kipping Congratulations! Well deserved

[Andrew Lipsky @andrewlipskymd]

@guildsman @nyulisom @NYULangoneLI @docbraunstein They Could not have made a better pick, congrats Dr. Shusterman

[Othman Al-Sawaf @Othman_Al_Sawaf]

Nice study by @herishanu et al @BloodJournal on Covid-vax in CLL:https://t.co/OvLR5O8BmJ
- response rate 40% in 167 pts
- response in tn > rrCLL; under treatment<remission
- response with BTKi and Bcl2i+CD20 impaired👇

=> CLL pts should receive vax whenever available
=> booster?

[Med Peds Hospitalist @medpedshosp]

Dr. Jorge Monge ⁦@JMongeMD⁩ from ⁦@WeillCornell⁩ delivering a superb ⁦@ClevelandClinic⁩ Hospital Medicine Grand Rounds on “Monoclonal Gammopathies”. #meded #foamed ⁦#nationalspeaker

[J Mark Sloan @Jmarksloan]

Every leukemia survivor owes their life to this extraordinary man. Pioneer of platelet transfusions and multi-agent chemotherapy. The reason our wards are no longer ‘abbatoirs’ is because of his work.

https://t.co/hHyjWxMQg9

[Andrew Lipsky @andrewlipskymd]

A privilege to write with the multitalented @dmarchalik in @TheLancet. Here, we synthesize insights from modern philosophy and Russian literature to help better understand the challenges inherent to physician training and pandemic redeployment. https://t.co/iTPg8mqwIs

[Andrew Lipsky @andrewlipskymd]

@JohnPLeonardMD @landau_lab This tweet is false https://t.co/QjdaCOHcUT

[Andrew Lipsky @andrewlipskymd]

Kudos to Danny is for sure in order! He also received an #ASH honors award for our single cell analysis of BTKi resistance. With top notch chops in biostatistics and bioinformatics, Danny is guaranteed to be a rising star for many ASH’s to come! Well deserved, Danny! #ASHKudos

[WCM Lymphoma @WCMLymphoma]

#ASHKudos - @WeillCornell medical student Danny Luan, under the mentorship of Dr. Peter Martin, received a 2020 ASH Abstract Achievement Award for #research on staging in diffuse large B-cell #lymphoma (#DLBCL). https://t.co/DyrA1whXr6 #ASH20 #lymsm

[Andrew Lipsky @andrewlipskymd]

@Jessica_Okosun Thanks Jessica! Would be very interesting indeed to look at TP53, techniques are on the horizon that may make this easier. It’s an exciting time !

[Andrew Lipsky @andrewlipskymd]

@JMongeMD @ASH_hematology @WCMLymphoma @columbiacancer Thanks Dr. Monge! Great that you’re stateside again...Myeloma community is lucky to have you back !

[Andrew Lipsky @andrewlipskymd]

Excited to present our work on subclonal BTK resistance in #CLL at #ASH20. An honor and a privilege to work with @landau_lab @richardFurmanMD @chaligneRonan @AnnaEnim @WCMLymphoma @Columbiacancer See you at session 641 ! https://t.co/7fCB9TSw00…

[Moses-Weiler Internal Medicine Residency @montefioreIM]

Congrats to our amazing residents who matched at such great fellowship programs! ⁦@einsteinmedicin⁩ ⁦@MontefioreNYC⁩ ⁦@EinsteinMed⁩

[Andrew Lipsky @andrewlipskymd]

Excellent #ASH20 educational preview with Dr. Lamanna @columbiacancer presenting clinical pearls for the management of BTK inhibitor toxicities in #CLL. On the lookout 👀 for the hematology2020 education 📖 in digital format!